Art therapy can help individuals express thoughts and feelings without relying solely on words, providing a valuable outlet ...

The distress from voices heard by schizophrenia patients were lessened when treated using digital avatars, new study showed.

Intra-Cellular Therapies' lumateperone shows significant efficacy in reducing schizophrenia relapse rates, with a 63% risk ...

Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...

Research suggests relapses can lead to harm, reduce the quality of life, and have a heavy economic impact on patients with ...

Lumateperone, an atypical antipsychotic, is currently approved under the brand name Caplyta for the treatment of schizophrenia in adults.

Are family-based interventions effective and safe for people with schizophrenia and their families, compared with standard care?

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced new, positive data on social ...

However, many are surprised to learn that one in 17 American adults lives with a serious mental illness, such as bipolar I disorder or schizophrenia. Bipolar I disorder is one of the most common ...

Most patients’ out-of-pocket costs will be much lower, depending on insurance and other factors. One cheaper generic called clozapine is widely considered one of the best treatments for schizophrenia, ...

Yoga appeared to be the most effective exercise for schizophrenia symptom control, according to a recent systematic review and meta-analysis.